Williams syndrome (WS) is rare—but rare is real.
Williams syndrome (WS) is a rare genetic condition caused by the deletion of approximately 26–28 genes on chromosome 7. Among those missing genes is the elastin (ELN) gene, which plays an important role in the development and function of blood vessels and connective tissue throughout the body.
Affecting approximately 1 in 10,000 people worldwide, Williams syndrome can present a complex range of medical and developmental challenges. Cardiovascular abnormalities are one of the most significant concerns, including narrowing of major blood vessels. Individuals with WS may also experience developmental and intellectual disabilities, anxiety, hearing loss, musculoskeletal conditions, and other health challenges that can require lifelong monitoring and specialized care.
Yet despite the very real medical challenges associated with Williams syndrome, there is currently no approved medication or therapeutic treatment specifically for WS.
That reality is at the heart of why research matters.
Every study brings greater understanding. Every discovery has the potential to bring us closer to better care, better treatments, and new possibilities for individuals with Williams syndrome.
That is why continued research, medical awareness, and support are so critical to improving and protecting the lives of individuals living with WS.

Approximately 1 in 10,000 people worldwide are affected by Williams syndrome.
An estimated 30,000 people in the United States are living with Williams syndrome.
Williams syndrome is caused by the deletion of approximately 26-28 genes on chromosome 7, in the 7q11-23 region.
Approximately 80% of individuals with Williams syndrome have cardiovascular abnormalities,
most commonly narrowing of the aorta and other blood vessels.
Learning disabilities and developmental delays are common, although abilities and challenges vary greatly from person to person.
Anxiety and behavioral challenges can impact everyday life.
Hearing loss and increased sensitivity to sound are more common among individuals with Williams syndrome.
Williams syndrome can affect bones, joints, muscles, and connective tissue.
Williams Syndrome affects each individual differently - no two people are exactly alike. There is currently no approved medication or therapeutic treatment specifically for Williams Syndrome, making continued research critical to improving care, treatment and quality of life.
For many individuals with Williams syndrome, cardiovascular disease is one of the most serious and potentially life-threatening aspects of the condition.
The deletion that causes Williams syndrome includes the elastin (ELN) gene, which plays an essential role in the structure and function of blood vessels. As a result, individuals with WS can develop narrowing of major arteries, including the aorta and pulmonary arteries, which can affect normal blood flow throughout the body.
Approximately 80% of individuals with Williams syndrome have cardiovascular abnormalities, and an estimated 25–30% may require cardiac surgery during their lifetime.
Cardiovascular complications can also make routine medical care more complex. Individuals with WS may face an increased risk of serious complications during sedation and anesthesia, including sudden cardiac events. For these reasons, making appropriate cardiovascular evaluation, specialized medical care, and awareness among healthcare professionals especially important.
This is why cardiovascular research matters. Greater understanding can lead to earlier detection, safer medical and surgical care, better treatments—and ultimately, longer and healthier lives for individuals with Williams syndrome.
The heart is at the center of some of the greatest medical challenges in WS. Research can help change what comes next.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.